An international team found inhibiting IL-11 in mice extended lifespan, prompting human trials for age-related conditions, but long-term safety is uncertain.
Accumulated damaged proteins and chemicals trigger inflammation in aging bodies, leading to detrimental long-term health effects like cancer and fibrosis.
Collection
[
|
...
]